Peter N. Pferschy

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski, Ewald Kolesnik, Norbert J. Tripolt et al. · European Heart Journal · 2022 · 266 citations · Full text

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial

Anna Obermayer, Norbert J. Tripolt, Peter N. Pferschy et al. · Diabetes Care · 2022 · 96 citations · Full text

Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial

Norbert J. Tripolt, Ewald Kolesnik, Peter N. Pferschy et al. · American Heart Journal · 2019 · 70 citations

Cardiac Function, Heart Failure, Cardiovascular Disease +6

Humoral immune response to <scp>COVID‐19</scp> vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective <scp>COVAC‐DM</scp> cohort study

Caren Sourij, Norbert J. Tripolt, Faisal Aziz et al. · Diabetes Obesity and Metabolism · 2022 · 63 citations · Full text

Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial

Othmar Moser, Max L. Eckstein, Alexander Mueller et al. · Diabetic Medicine · 2019 · 38 citations · Full text